224 related articles for article (PubMed ID: 33094561)
1. IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.
Huang W; Li Y; Zhang C; Zha H; Zhou X; Fu B; Guo J; Wang G
J Cell Mol Med; 2020 Dec; 24(23):13949-13960. PubMed ID: 33094561
[TBL] [Abstract][Full Text] [Related]
2. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma.
Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C
Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196
[TBL] [Abstract][Full Text] [Related]
3. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
4. The Polyhomeotic protein induces hyperplastic tissue overgrowth through the activation of the JAK/STAT pathway.
González I; Simón R; Busturia A
Cell Cycle; 2009 Dec; 8(24):4103-11. PubMed ID: 19923887
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
Wang J; Ma W; Liu Y
Cancer Biomark; 2017 Dec; 20(4):425-434. PubMed ID: 28946549
[TBL] [Abstract][Full Text] [Related]
6. NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway.
Wang H; Fu Y
BMC Cancer; 2021 Jul; 21(1):871. PubMed ID: 34330232
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.
Fan J; Zhuang M; Fan W; Hou M
PeerJ; 2023; 11():e15706. PubMed ID: 37663284
[TBL] [Abstract][Full Text] [Related]
8. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
9. Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo.
Xu W; Sheng Y; Guo Y; Huang Z; Huang Y; Wen D; Liu CY; Cui L; Yang Y; Du P
J Cell Physiol; 2019 Aug; 234(10):18466-18479. PubMed ID: 30895618
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
[TBL] [Abstract][Full Text] [Related]
11. CPEB3 functions as a tumor suppressor in colorectal cancer via JAK/STAT signaling.
Fang Y; Zhong Q; Wang Y; Gu C; Liu S; Li A; Yan Q
Aging (Albany NY); 2020 Nov; 12(21):21404-21422. PubMed ID: 33146632
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation.
Sun Y; Cheng MK; Griffiths TR; Mellon JK; Kai B; Kriajevska M; Manson MM
Curr Cancer Drug Targets; 2013 Jan; 13(1):57-68. PubMed ID: 22920439
[TBL] [Abstract][Full Text] [Related]
13. Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Shi R; Yu X; Wang Y; Sun J; Sun Q; Xia W; Dong G; Wang A; Gao Z; Jiang F; Xu L
Tumour Biol; 2017 Apr; 39(4):1010428317695928. PubMed ID: 28381175
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2.
Ren W; Wu S; Wu Y; Liu T; Zhao X; Li Y
Cell Death Dis; 2019 Apr; 10(5):333. PubMed ID: 30988277
[TBL] [Abstract][Full Text] [Related]
16. IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development.
Lv L; Wei Q; Zhang J; Dong Y; Shan Z; Chang N; Zhao Y; Bian P; Yi Q
Cell Mol Biol Lett; 2024 Mar; 29(1):39. PubMed ID: 38504159
[TBL] [Abstract][Full Text] [Related]
17. JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer.
Bagratuni T; Mavrianou N; Gavalas NG; Tzannis K; Arapinis C; Liontos M; Christodoulou MI; Thomakos N; Haidopoulos D; Rodolakis A; Kastritis E; Scorilas A; Dimopoulos MA; Bamias A
Eur J Cancer; 2020 Feb; 126():125-135. PubMed ID: 31927213
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
He HC; Ling XH; Zhu JG; Fu X; Han ZD; Liang YX; Deng YH; Lin ZY; Chen G; Chen YF; Mo RJ; Zhong WD
Mol Biol Rep; 2013 May; 40(5):3799-805. PubMed ID: 23283744
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
Liang W; Xia B; He C; Zhai G; Li M; Zhou J
Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554
[TBL] [Abstract][Full Text] [Related]
20. MTHFD2 promotes PD-L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer.
Li L; Zhang Y; Hu W; Zou F; Ning J; Rao T; Ruan Y; Yu W; Cheng F
J Cell Mol Med; 2023 Oct; 27(19):2922-2936. PubMed ID: 37480214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]